References

1. Macfarlane TV, Kincey J, Worthington HV. The association between psychological factors and oro-facial pain: a community-based study. Eur J Pain 2002; 6: 427-434.

2. Turp JC. Temporomandibular Pain - Clinical Presentation and Impact. Quintessenz Verlags-GmbH, Berlin, 2000.

3. Woda A, Tubert-Jeannin S, Bouhassira D, et al. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005; 116: 396-406.

4. Zakrzewska JM. Facial pain: an update. Curr Opin Support Palliat Care 2009; 3: 125-130.

5. Zakrzewska JM, Harrison SD Assessment and Management of Orofacial Pain. Elsevier Science, Amsterdam, 2002.

6. Zakrzewska JM. Orofacial Pain. Oxford, Oxford University Press, 2009.

7. Elrasheed AA, Worthington HV, Ariyaratnam S, Duxbury AJ. Opinions of UK specialists about terminology, diagnosis, and treatment of atypical facial pain: a survey. Br J Oral Maxillofac Surg 2004; 42: 566-571.

8. Zakrzewska JM, Hamlyn PJ. Facial pain. In: Crombie I, Linton SJ, LeResche L, von Korff M (eds) Epidemiology of Pain. IASP Press, Seattle, 1999: 171-202.

9. Aggarwal VR, Lunt M, Zakrzewska JM, Macfarlane GJ, Macfarlane TV. Development and validation of the Manchester orofacial pain disability scale. Community Dent Oral Epidemiol 2005; 33: 141-149.

10. Feinmann C. The long-term outcome of facial pain treatment. J Psychosom Res 1993; 37: 381-387.

11. International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004; 2(suppl 1): 9-160.

12. Zebenholzer K, Wober C, Vigl M, Wessely P, Wober-Bingol C. Facial pain in a neurological tertiary care centre - evaluation of the International Classification of Headache Disorders. Cephalalgia 2005; 25: 689-699.

13. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-227.

14. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005454. DOI: 10.1002/14651858.CD005454.pub2.

15. Feinmann C, Harris M. Psychogenic facial pain. Part 2: Management and prognosis. Br Dent J 1984; 156: 205-208.

16. Harrison SD, Glover L, Feinmann C, Pearce SA, Harris M. A comparison of antidepressant medication alone and in conjunction with cognitive behavioural therapy for chronic idiopathic facial pain. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z. Proceedings of the 8th World Congress on Pain. Progress in Pain Research and Management. IASP Press, Seattle, 1997: 663-672.

17. Lascelles RG. Atypical facial pain and depression. Br J Psychiatry 1966; 112: 651-659.

18. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 2003; 17: 301-310.

19. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987; 31: 199-209.

20. Forsell H, Tasmuth T, Tenovuo O, Hampf G, Kalso E. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. J Orofac Pain 2004; 18: 131-137.

21. al Balawi S, Tariq M, Feinmann C. A double-blind, placebo-controlled, crossover, study to evaluate the efficacy of subcutaneous sumatriptan in the treatment of atypical facial pain. Int J Neurosci 1996; 86: 301-309.

22. Williams AC. Cognitive behavioral treatment.In: Dostrovsky JO, Carr DB, Koltzenburg M (eds) Proceedings of the 10th World Congress on Pain. IASP Press, Seattle, 2003: 825-837.

23. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992; 6: 301-355.

24. Drangsholt M, LeResche L. Temporomandibular disorder pain. In: Crombie I, Linton SJ, LeResche L, von Korff M (eds) Epidemiology of Pain. IASP Press, Seattle, 1999: 203-233.

25. Laskin DM, Greene CS, Hylander WL. TMDs: An Evidence-Based Approach to Diagnosis and Treatment Quintessence, New Maiden, Surrey, 2006.

26. Gesch D, Bernhardt O, Kirbschus A. Association of malocclusion and functional occlusion with temporomandibular disorders (TMD) in adults: a systematic review of population-based studies. Quintessence Int 2004; 35: 211-221.

27. von Korff M, Dworkin SF, LeResche L. Graded chronic pain status: an epidemiologic evaluation. Pain 1990; 40: 279-291.

28. Antczak-Bouckoms AA. Epidemiology of research for temporomandibular disorders. J Orofac Pain 1995; 9: 226-234.

29. Dworkin SF, Turner JA, Mancl L, et al. A randomized clinical trial of a tailored comprehensive care treatment program for temporomandibular disorders. J Orofac Pain 2002; 16: 259-276.

30. Gardea MA, Gatchel RJ, Mishra KD. Long-term efficacy of biobehavioral treatment of temporomandibular disorders. J Behav Med 2001; 24: 341-359.

31. Mishra KD, Gatchel RJ, Gardea MA. The relative efficacy of three cognitive-behavioral treatment approaches to tempo-romandibular disorders. J Behav Med 2000; 23: 293-309.

32. Turner JA, Mancl L, Aaron LA. Short- and long-term efficacy of brief cognitive-behavioral therapy for patients with chronic temporomandibular disorder pain: a randomized, controlled trial. Pain 2006; 121: 181-194.

33. Gatchel RJ, Stowell AW, Wildenstein L, Riggs R, Ellis E III. Efficacy of an early intervention for patients with acute temporomandibular disorder-related pain: a one-year outcome study. J Am Dent Assoc 2006; 137: 339-347.

34. Al-Ani MZ, Davies SJ, Gray RJM, Sloan P, Glenny AM. Stabilisation splint therapy for temporomandibular pain dysfunction syndrome. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD002778. DOI: 10.1002/14651858.CD002778.pub2.

35. Forsell H, Kalso E, Koskela P, Vehmanen R, Puukka P, Alanen P. Occlusal treatments in temporomandibular disorders: a qualitative systematic review of randomized controlled trials. Pain 1999; 83: 549-560.

36. De Boever JA, Nilner M, Orthlieb JD et al. Recommendations by the EACD for examination, diagnosis, and management of patients with temporomandibular disorders and orofacial pain by the general dental practitioner. J Orofac Pain 2008; 22: 268-278.

37. Gerschman JA, Reade PD, Burrows GD. Evaluation of a proprietary analgesic/antihistamine in the management of pain associated with temporomandibular joint pain dysfunction syndrome. Aust Dent J 1984; 29: 300-304.

38. Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain 1997; 11: 139-146.

39. Plesh O, Curtis D, Levine J, McCall WD Jr. Amitriptyline treatment of chronic pain in patients with temporoman-dibular disorders. J Oral Rehabil 2000; 27: 834-841.

40. Koh H, Robinson P. Occlusal adjustment for treating and preventing temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD003812. DOI: 10.1002/14651858.CD003812.

41. Jedel E, Carlsson J. Biofeedback, acupuncture and transcutaneous electric nerve stimulation in the management of temperomandibular disorders: a systematic review. Phys Ther Rev 2003; 8: 217-223.

42. Ernst E, White AR. Acupuncture as a treatment for temporomandibular joint dysfunction: a systematic review of randomized trials. Arch Otolaryngol Head Neck Surg 1999; 125: 269-272.

43. Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomandib Disord 1991; 5: 179-186.

44. Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain 2002; 99: 465-473.

45. Ohrbach R, Sherman J. Temporomandibular disorders. In: Dworkin RH, Breitbart WS (eds) Psychosocial Aspects of Pain: A Handbook for Health Care Providers. IASP Press, Seattle, 2004: 405-425.

46. Merskey H, Bogduk N. Classification of Chronic Pain. Descriptors of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd edn. IASP Press, Seattle, 1994.

47. Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 2002; 18: 4-13.

48. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001; 124: 2347-2360.

49. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006; 122: 156-162.

50. Eller JL, Raslan AM, Burchiel KJ. Trigeminal neuralgia: definition and classification. NeurosurgFocus 2005; 18: E3.

51. Nurmikko TJ, Eldridge PR. Trigeminal neuralgia - patho-physiology, diagnosis and current treatment. Br J Anaesth 2001; 87: 117-132.

52. Zakrzewska JM, Sawsan J, Bulman JS. A prospective, longitudinal study on patients with trigeminal neuralgia who underwent radiofrequency thermocoagulation of the Gasserian ganglion. Pain 1999; 79: 51-58.

53. Cruccu G, Gronseth G, Alksne J et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013-1028.

54. Gronseth G, Cruccu G, Alksne J et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71: 1183-1190.

55. Wiffen PJ, Collins S, McQuay HJ, Carroll D, Jadad A, Moore RA. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001133. DOI: 10.1002/14651858.CD001133.pub2.

56. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005451. DOI: 10.1002/14651858.CD005451.

57. He L, Wu B, Zhou M. Non-antiepileptic drugs for trigemi-nal neuralgia. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004029. DOI: 10.1002/14651858. CD004029.pub2.

58. Zakrzewska JM, Linskey ME. Trigeminal neuralgia. Clin Evid (Online ) 2009; pii, 1207.

59. Lemos L, Flores S, Oliveira P et al. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain 2008; 24: 64-75.

60. Zakrzewska JM. Trigeminal neuralgia. In: Zakrzewska JM, Harrison SD (eds) Assessment and Management of Orofacial Pain. Elsevier Sciences, Amsterdam, 2002: 267-370.

61. Zakrzewska JM, Lopez BC. Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports. Neurosurgery 2003; 53: 110-122.

62. Obermann M, Yoon MS, Sensen K et al. Efficacy of prega-balin in the treatment of trigeminal neuralgia. Cephalalgia 2008; 28: 174-181.

63. Regis J, Metellus P, Hayashi M, Roussel P, Donnet A, Bille-Turc F. Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia. J Neurosurg 2006; 104: 913-924.

64. Zakrzewska JM, Lopez BC, Kim SE, Coakham HB. Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia. Neurosurgery 2005; 56: 1304-1311.

65. Weigel G, Casey KF. Striking Back. The Trigeminal Neuralgia Handbook. Trigeminal Neuralgia Association, Gainesville, FL, 2000.

66. Zakrzewska JM. Insights: Facts and Stories Behind Trigeminal Neuralgia. Trigeminal Neuralgia Association, Gainesville, FL, 2006.

Beat Depression Today

Beat Depression Today

I know this is hard for you to believe. I mean, to be able to be totally free of depression in such little time... and without any effort... not to mention the freedom to live your life, appear hard to fulfill at first glance... That is until you know the facts On a subconscious level, you will experience an incredible and exclusive Tri- Enhanced trance state of hypnosis to reprogram your mind to free you from negatize emotions.

Get My Free Ebook


Post a comment